Some elegantly simple results of Defendi, Ephrussi et al. … have provided strong support for the general hypothesis that cancer induced by virus results from the addition of genetic information.
Uncontrolled growth is the characteristic property that distinguishes all cancer cells from normal cells. Cancer cells are unable to regulate cell division and, since this characteristic is inherited, it is highly likely that it results from a genetic change. Before the discovery that DNA and RNA viruses can both transform normal cells into cancer cells, the hypothesis most frequently considered was that cancer is caused by the accumulation of somatic mutations leading to the loss of the function of some essential regulatory gene. With the discovery of cancer inducing or oncogenic viruses, an alternative hypothesis could be considered-that cancer results from the acquisition of genetic information. … it is equally possible that oncogenic viruses either cause a deletion of part of the cell genome or induce recessive mutations. The crucial question then is whether the genome of an oncogenic virus persists in transformed cells, perhaps incorporated into the chromosome as a prophage is in a bacterium. From Nature 22 April 1967
Years Ago
To gain daylight by adjustment of the clock is a brilliant practical idea, but the present method of realising it by moving the hands of the clock is grossly unscientific, and should, I think, be changed for the alternative one.
Let the circular disc of the clockdial be put in place by screws in curved slots. … when changing time, we should rotate the dial backwards and forwards respectively, leaving the hands untouched. From Nature 19 April 1917 surface lakes could provide the tipping point, which, once reached, would trigger the breakup of an ice shelf. If this is true, many ice shelves could be exposed to an ever-increasing risk of break-up, given their already extensive lake coverage. However, such a threshold might not be reached if surface water can instead be efficiently exported from the ice shelf to the ocean through large river networks.
Various physical factors will determine which of the above processes dominates for individual ice shelves. For example, relatively flat topography and extensive snow coverage will encourage surface-water ponding, which is likely to increase instability (Fig. 1a) . Conversely, steeper slopes and bare ice surfaces will encourage water flow and stream development, potentially offsetting some of this increased instability (Fig. 1b) . The latter scenario is not currently accounted for by icesheet models, which assume that all meltwater is stored on top of ice shelves, making them increasingly unstable. For example, the results of these models suggest that some of Antarctica's major ice shelves -such as the Amery, Filchner-Ronne, Larsen C and Ross -will disintegrate after melt rates exceed 1.5 metres per year, in the next century 3 . However, Bell and colleagues' analysis of the surface topography of these four ice shelves puts this prediction into question.
These two studies suggest that the surface hydrology on Antarctica's ice shelves will play a crucial part in deciding their individual fates, and those of the outlet glaciers that feed them. However, the authors do not explicitly address the likely additional role of increased melting on the undersides of ice shelves caused by ocean warming 4 . Given that the Antarctic Ice Sheet contains enough ice to raise global sea levels by 60 m (ref. 13 
C H R I STO P H E R G . TAT E
T hroughout the human body, the coordination of cell activity by hormones and neurotransmitter molecules is mediated by a multitude of cell-membrane proteins known as G-protein-coupled receptors (GPCRs). These form the largest membranereceptor family in humans, and are implicated in a range of disorders and diseases, including high blood pressure, migraine and cancer. It is essential for scientists to understand both the pharmacology and the structures of these receptors to develop new therapeutics. On page 327, Zhang et al. 1 describe the crystal structure of a particularly enigmatic GPCR, the angiotensin II type 2 receptor (AT 2 R), which is a potential target for the treatment of cardiovascular disease 2 . Unexpectedly, its structure deviates from the conventional GPCR structure, a finding that might explain its unusual signalling behaviour.
The structures of GPCRs are highly evolutionarily conserved, despite having widely divergent amino-acid sequences 3 . Each GPCR has two main structural states: inactive,
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A receptor that might block itself
The structure of the angiotensin II type 2 receptor reveals a potential mode of self-blocking action. This might explain its lack of signalling, and opens up avenues of investigation into its function and role in disease. See Article p.327 which usually predominates; and active, which occurs when the receptor binds to an activating molecule (an agonist) such as a hormone. Hormones bind to a deep pocket on the receptor's extracellular surface, causing the formation of a cleft on its intracellular surface. On binding to the cleft, the G protein is activated and ultimately changes the concentration of intracellular signalling molecules, hence changing the cellular biochemistry.
The hormone angiotensin II is a key regulator of blood pressure that acts through binding to two angiotensin receptors, AT 1 R and AT 2 R, which are both GPCRs and share approximately 34% of their amino-acid sequences. AT 1 R is a well-characterized, typical GPCR that activates G proteins as well as signalling through the protein β-arrestin. It is the site of action of drugs known as angiotensin II receptor blockers, which are used to treat high blood pressure. By contrast, it has not been possible to show that angiotensin induces AT 2 R to signal through G proteins or β-arrestin Similarly, the authors observe that there is no intracellular cleft available for G-protein binding in the AT 2 R structure. Instead, this site is occupied by a short α-helix (H8) that is found after the final transmembrane α-helix (H7) of most GPCRs (Fig. 1) . Therefore, the conformation of AT 2 R observed in Zhang and colleagues' structure would not be expected to activate either a G protein or β-arrestin. As in the case of A 2A R (ref. 8) , only a few changes to the activelike conformation of AT 2 R would be needed for the receptor to adopt the fully active state.
Could the position in which H8 is observed in the AT 2 R crystal structure be an artefact associated with the crystallization of the receptor? The authors argue that this is unlikely, given that the positioning is observed in two different crystal forms of AT 2 R. More tellingly, Zhang et al. performed molecular-dynamics simulations of AT 2 R in which H8 had been moved away from the core of the receptor. During these simulations, H8 moved to the position identified in the crystal structure.
It is certainly tempting to believe that H8 adopts this conformation in vivo, because this model would explain why G-protein and β-arrestin coupling to angiotensin-bound AT 2 R has not been observed, despite the receptor having all the hallmarks of a typical GPCR. Such a model would also describe a previously unknown function for H8 and a new activelike state for GPCRs. The crystal structure 5 of the active-like state of NTSR1 does provide some evidence to suggest that H8 could adopt a similar position to that observed in AT 2 R, but molecular-dynamics simulations 9 have shown that, in the active-like state, H8 in NTSR1 is intrinsically unstable and does not form a helix such as that observed in AT 2 R.
The H8-inhibited AT 2 R structure raises many questions. For example, Zhang and colleagues co-crystallized the receptor with two ligand molecules -do these function as agonists or as antagonists (receptor blockers) in vivo? Moreover, in the absence of a crystal structure of AT 2 R in the inactive state bound to an antagonist, it is unclear whether H8 always adopts the conformation observed in Zhang and colleagues' structure, regardless of what ligand is bound.
If H8 is essential to blocking G-protein signalling from AT 2 R, would selective mutations or truncations of this region allow signalling through G proteins? Indeed, can H8 move out of the binding cleft through random motions on a timescale that would allow G-protein signalling? If so, then G-protein coupling is a possibility, just on a slow timescale.
A potential regulator of G-protein signalling for AT 2 R is a chemical modification known as palmitoylation, which occurs at the carboxy terminus of other GPCRs (ref. 10) -but it is not known whether AT 2 R is palmitoylated. There is also increasing evidence that AT 2 R signals through pathways 4 that require soluble proteins such as ATIP and SHP-1. However, it is not clear how these proteins could be activated only by agonist binding to AT 2 R. Another possibility is that AT 2 R doesn't itself signal through G proteins, but instead modulates the G-protein signalling of AT 1 R by forming a complex (heterodimer) with that receptor 11 . The unusual pharmacology of AT 2 R has been a puzzle for many years. Zhang and colleagues' structure provides the first insight into what might underpin this unusual behaviour. Understanding why AT 2 R has evolved not to couple to G proteins or β-arrestin is a challenge for future work. Researchers should also investigate how many other GPCRs share this curious characteristic. Far from being just a peripheral appendage to a GPCR, H8 might have a much more important and diverse role in GPCR signalling than was previously suspected. ■ Christopher G. 
